World Journal of Gastrointestinal Oncology-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2111599, encodeId=3ab5211159967, content=偏重的研究方向：肿瘤;胃肠 经验分享：邀请投稿，第一个审稿人评分DC，给的大修，不知道会不会给大修的机会😔, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab055420094, createdName=少年宁, createdTime=Fri Jan 27 10:22:04 CST 2023, time=2023-01-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=588958, encodeId=da425889587c, content=结果怎么样？审稿快吗？136bxNT2201(暂无昵称) 2019-09-21 00:00:00 发表: 投了, beContent=136bxNT2201(暂无昵称) 2019-09-21 00:00:00 发表: 投了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa555318674, createdName=148a31cbm82暂无昵称, createdTime=Wed Apr 15 00:00:00 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203712, encodeId=341b1203e12de, content=一个case而已，超级多审稿人，用的着吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/11/27/02ec99199da3be64e02e6f44937ab158.jpg, createdBy=1c582101660, createdName=john2525, createdTime=Fri Mar 18 09:38:37 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966262, encodeId=79fa9662623a, content=请问有没有投中的啊 2.22投现在还在under review 毕业想撤稿了😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2ea65502954, createdName=zhangy, createdTime=Mon May 17 14:37:00 CST 2021, time=2021-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211284, encodeId=9f4512112849b, content=那个提交稿件统计学证明，大佬都在呢整得哇，求助。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220410/72abed6ca19c4aca86961c1291a3a3c6/e23fe3265bd64221b9f3d1f39f00a99f.jpg, createdBy=6a3e5632321, createdName=燚燚燚, createdTime=Thu Apr 14 22:34:11 CST 2022, time=2022-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098499, encodeId=172e20984998e, content=reviewed 是在什么阶段, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c992146749, createdName=经胸微创, createdTime=Fri Nov 04 15:25:14 CST 2022, time=2022-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2163083, encodeId=71d2216308318, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：食管癌 经验分享：有没有人知道这个期刊的审稿状态啊，reviewing是什么阶段啊，求大佬告知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af406151852, createdName=ms8000000868362155, createdTime=Mon Oct 16 15:24:30 CST 2023, time=2023-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225203, encodeId=9afb122520311, content=偏重的研究方向：肿瘤 经验分享：投稿1个月了，AI发送了很多审稿人，到现在也没有一个审稿意见，很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ffe2800746, createdName=504528319, createdTime=Wed Jun 08 15:27:15 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566145, encodeId=bb1a56614542, content=没有人投这个杂志吗？一点信息都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/12/28/80eebc88df7aaad2c9eb32ecfb284595.jpg, createdBy=cbef1645356, createdName=ysynl, createdTime=Fri Jan 25 00:00:00 CST 2019, time=2019-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2194080, encodeId=2ef6219408091, content=偏重的研究方向：肿瘤;食管癌;胃肠 经验分享：肠胃相关都可以发，头像找我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231027/c966878f146e4e0dbf8418b9b86fbb57/c2d7036599894bf0b8f0dd9085325554.jpg, createdBy=54379018170, createdName=ms4000000361701675, createdTime=Tue Mar 19 15:26:51 CST 2024, time=2024-03-19, status=1, ipAttribution=广西)]

2023-01-27 少年宁来自浙江省

偏重的研究方向：肿瘤;胃肠
经验分享：邀请投稿，第一个审稿人评分DC，给的大修，不知道会不会给大修的机会😔

48 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2111599, encodeId=3ab5211159967, content=偏重的研究方向：肿瘤;胃肠 经验分享：邀请投稿，第一个审稿人评分DC，给的大修，不知道会不会给大修的机会😔, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab055420094, createdName=少年宁, createdTime=Fri Jan 27 10:22:04 CST 2023, time=2023-01-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=588958, encodeId=da425889587c, content=结果怎么样？审稿快吗？136bxNT2201(暂无昵称) 2019-09-21 00:00:00 发表: 投了, beContent=136bxNT2201(暂无昵称) 2019-09-21 00:00:00 发表: 投了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa555318674, createdName=148a31cbm82暂无昵称, createdTime=Wed Apr 15 00:00:00 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203712, encodeId=341b1203e12de, content=一个case而已，超级多审稿人，用的着吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/11/27/02ec99199da3be64e02e6f44937ab158.jpg, createdBy=1c582101660, createdName=john2525, createdTime=Fri Mar 18 09:38:37 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966262, encodeId=79fa9662623a, content=请问有没有投中的啊 2.22投现在还在under review 毕业想撤稿了😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2ea65502954, createdName=zhangy, createdTime=Mon May 17 14:37:00 CST 2021, time=2021-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211284, encodeId=9f4512112849b, content=那个提交稿件统计学证明，大佬都在呢整得哇，求助。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220410/72abed6ca19c4aca86961c1291a3a3c6/e23fe3265bd64221b9f3d1f39f00a99f.jpg, createdBy=6a3e5632321, createdName=燚燚燚, createdTime=Thu Apr 14 22:34:11 CST 2022, time=2022-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098499, encodeId=172e20984998e, content=reviewed 是在什么阶段, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c992146749, createdName=经胸微创, createdTime=Fri Nov 04 15:25:14 CST 2022, time=2022-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2163083, encodeId=71d2216308318, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：食管癌 经验分享：有没有人知道这个期刊的审稿状态啊，reviewing是什么阶段啊，求大佬告知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af406151852, createdName=ms8000000868362155, createdTime=Mon Oct 16 15:24:30 CST 2023, time=2023-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225203, encodeId=9afb122520311, content=偏重的研究方向：肿瘤 经验分享：投稿1个月了，AI发送了很多审稿人，到现在也没有一个审稿意见，很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ffe2800746, createdName=504528319, createdTime=Wed Jun 08 15:27:15 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566145, encodeId=bb1a56614542, content=没有人投这个杂志吗？一点信息都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/12/28/80eebc88df7aaad2c9eb32ecfb284595.jpg, createdBy=cbef1645356, createdName=ysynl, createdTime=Fri Jan 25 00:00:00 CST 2019, time=2019-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2194080, encodeId=2ef6219408091, content=偏重的研究方向：肿瘤;食管癌;胃肠 经验分享：肠胃相关都可以发，头像找我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231027/c966878f146e4e0dbf8418b9b86fbb57/c2d7036599894bf0b8f0dd9085325554.jpg, createdBy=54379018170, createdName=ms4000000361701675, createdTime=Tue Mar 19 15:26:51 CST 2024, time=2024-03-19, status=1, ipAttribution=广西)]

2020-04-15 148a31cbm82暂无昵称

结果怎么样？审稿快吗？136bxNT2201(暂无昵称) 2019-09-21 00:00:00 发表:
投了

136bxNT2201(暂无昵称) 2019-09-21 00:00:00 发表: 投了

115 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2111599, encodeId=3ab5211159967, content=偏重的研究方向：肿瘤;胃肠 经验分享：邀请投稿，第一个审稿人评分DC，给的大修，不知道会不会给大修的机会😔, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab055420094, createdName=少年宁, createdTime=Fri Jan 27 10:22:04 CST 2023, time=2023-01-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=588958, encodeId=da425889587c, content=结果怎么样？审稿快吗？136bxNT2201(暂无昵称) 2019-09-21 00:00:00 发表: 投了, beContent=136bxNT2201(暂无昵称) 2019-09-21 00:00:00 发表: 投了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa555318674, createdName=148a31cbm82暂无昵称, createdTime=Wed Apr 15 00:00:00 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203712, encodeId=341b1203e12de, content=一个case而已，超级多审稿人，用的着吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/11/27/02ec99199da3be64e02e6f44937ab158.jpg, createdBy=1c582101660, createdName=john2525, createdTime=Fri Mar 18 09:38:37 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966262, encodeId=79fa9662623a, content=请问有没有投中的啊 2.22投现在还在under review 毕业想撤稿了😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2ea65502954, createdName=zhangy, createdTime=Mon May 17 14:37:00 CST 2021, time=2021-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211284, encodeId=9f4512112849b, content=那个提交稿件统计学证明，大佬都在呢整得哇，求助。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220410/72abed6ca19c4aca86961c1291a3a3c6/e23fe3265bd64221b9f3d1f39f00a99f.jpg, createdBy=6a3e5632321, createdName=燚燚燚, createdTime=Thu Apr 14 22:34:11 CST 2022, time=2022-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098499, encodeId=172e20984998e, content=reviewed 是在什么阶段, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c992146749, createdName=经胸微创, createdTime=Fri Nov 04 15:25:14 CST 2022, time=2022-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2163083, encodeId=71d2216308318, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：食管癌 经验分享：有没有人知道这个期刊的审稿状态啊，reviewing是什么阶段啊，求大佬告知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af406151852, createdName=ms8000000868362155, createdTime=Mon Oct 16 15:24:30 CST 2023, time=2023-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225203, encodeId=9afb122520311, content=偏重的研究方向：肿瘤 经验分享：投稿1个月了，AI发送了很多审稿人，到现在也没有一个审稿意见，很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ffe2800746, createdName=504528319, createdTime=Wed Jun 08 15:27:15 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566145, encodeId=bb1a56614542, content=没有人投这个杂志吗？一点信息都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/12/28/80eebc88df7aaad2c9eb32ecfb284595.jpg, createdBy=cbef1645356, createdName=ysynl, createdTime=Fri Jan 25 00:00:00 CST 2019, time=2019-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2194080, encodeId=2ef6219408091, content=偏重的研究方向：肿瘤;食管癌;胃肠 经验分享：肠胃相关都可以发，头像找我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231027/c966878f146e4e0dbf8418b9b86fbb57/c2d7036599894bf0b8f0dd9085325554.jpg, createdBy=54379018170, createdName=ms4000000361701675, createdTime=Tue Mar 19 15:26:51 CST 2024, time=2024-03-19, status=1, ipAttribution=广西)]

2022-03-18 john2525

一个case而已，超级多审稿人，用的着吗？

68 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2111599, encodeId=3ab5211159967, content=偏重的研究方向：肿瘤;胃肠 经验分享：邀请投稿，第一个审稿人评分DC，给的大修，不知道会不会给大修的机会😔, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab055420094, createdName=少年宁, createdTime=Fri Jan 27 10:22:04 CST 2023, time=2023-01-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=588958, encodeId=da425889587c, content=结果怎么样？审稿快吗？136bxNT2201(暂无昵称) 2019-09-21 00:00:00 发表: 投了, beContent=136bxNT2201(暂无昵称) 2019-09-21 00:00:00 发表: 投了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa555318674, createdName=148a31cbm82暂无昵称, createdTime=Wed Apr 15 00:00:00 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203712, encodeId=341b1203e12de, content=一个case而已，超级多审稿人，用的着吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/11/27/02ec99199da3be64e02e6f44937ab158.jpg, createdBy=1c582101660, createdName=john2525, createdTime=Fri Mar 18 09:38:37 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966262, encodeId=79fa9662623a, content=请问有没有投中的啊 2.22投现在还在under review 毕业想撤稿了😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2ea65502954, createdName=zhangy, createdTime=Mon May 17 14:37:00 CST 2021, time=2021-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211284, encodeId=9f4512112849b, content=那个提交稿件统计学证明，大佬都在呢整得哇，求助。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220410/72abed6ca19c4aca86961c1291a3a3c6/e23fe3265bd64221b9f3d1f39f00a99f.jpg, createdBy=6a3e5632321, createdName=燚燚燚, createdTime=Thu Apr 14 22:34:11 CST 2022, time=2022-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098499, encodeId=172e20984998e, content=reviewed 是在什么阶段, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c992146749, createdName=经胸微创, createdTime=Fri Nov 04 15:25:14 CST 2022, time=2022-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2163083, encodeId=71d2216308318, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：食管癌 经验分享：有没有人知道这个期刊的审稿状态啊，reviewing是什么阶段啊，求大佬告知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af406151852, createdName=ms8000000868362155, createdTime=Mon Oct 16 15:24:30 CST 2023, time=2023-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225203, encodeId=9afb122520311, content=偏重的研究方向：肿瘤 经验分享：投稿1个月了，AI发送了很多审稿人，到现在也没有一个审稿意见，很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ffe2800746, createdName=504528319, createdTime=Wed Jun 08 15:27:15 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566145, encodeId=bb1a56614542, content=没有人投这个杂志吗？一点信息都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/12/28/80eebc88df7aaad2c9eb32ecfb284595.jpg, createdBy=cbef1645356, createdName=ysynl, createdTime=Fri Jan 25 00:00:00 CST 2019, time=2019-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2194080, encodeId=2ef6219408091, content=偏重的研究方向：肿瘤;食管癌;胃肠 经验分享：肠胃相关都可以发，头像找我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231027/c966878f146e4e0dbf8418b9b86fbb57/c2d7036599894bf0b8f0dd9085325554.jpg, createdBy=54379018170, createdName=ms4000000361701675, createdTime=Tue Mar 19 15:26:51 CST 2024, time=2024-03-19, status=1, ipAttribution=广西)]

2021-05-17 zhangy

请问有没有投中的啊 2.22投现在还在under review 毕业想撤稿了😭😭

71 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2111599, encodeId=3ab5211159967, content=偏重的研究方向：肿瘤;胃肠 经验分享：邀请投稿，第一个审稿人评分DC，给的大修，不知道会不会给大修的机会😔, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab055420094, createdName=少年宁, createdTime=Fri Jan 27 10:22:04 CST 2023, time=2023-01-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=588958, encodeId=da425889587c, content=结果怎么样？审稿快吗？136bxNT2201(暂无昵称) 2019-09-21 00:00:00 发表: 投了, beContent=136bxNT2201(暂无昵称) 2019-09-21 00:00:00 发表: 投了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa555318674, createdName=148a31cbm82暂无昵称, createdTime=Wed Apr 15 00:00:00 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203712, encodeId=341b1203e12de, content=一个case而已，超级多审稿人，用的着吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/11/27/02ec99199da3be64e02e6f44937ab158.jpg, createdBy=1c582101660, createdName=john2525, createdTime=Fri Mar 18 09:38:37 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966262, encodeId=79fa9662623a, content=请问有没有投中的啊 2.22投现在还在under review 毕业想撤稿了😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2ea65502954, createdName=zhangy, createdTime=Mon May 17 14:37:00 CST 2021, time=2021-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211284, encodeId=9f4512112849b, content=那个提交稿件统计学证明，大佬都在呢整得哇，求助。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220410/72abed6ca19c4aca86961c1291a3a3c6/e23fe3265bd64221b9f3d1f39f00a99f.jpg, createdBy=6a3e5632321, createdName=燚燚燚, createdTime=Thu Apr 14 22:34:11 CST 2022, time=2022-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098499, encodeId=172e20984998e, content=reviewed 是在什么阶段, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c992146749, createdName=经胸微创, createdTime=Fri Nov 04 15:25:14 CST 2022, time=2022-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2163083, encodeId=71d2216308318, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：食管癌 经验分享：有没有人知道这个期刊的审稿状态啊，reviewing是什么阶段啊，求大佬告知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af406151852, createdName=ms8000000868362155, createdTime=Mon Oct 16 15:24:30 CST 2023, time=2023-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225203, encodeId=9afb122520311, content=偏重的研究方向：肿瘤 经验分享：投稿1个月了，AI发送了很多审稿人，到现在也没有一个审稿意见，很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ffe2800746, createdName=504528319, createdTime=Wed Jun 08 15:27:15 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566145, encodeId=bb1a56614542, content=没有人投这个杂志吗？一点信息都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/12/28/80eebc88df7aaad2c9eb32ecfb284595.jpg, createdBy=cbef1645356, createdName=ysynl, createdTime=Fri Jan 25 00:00:00 CST 2019, time=2019-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2194080, encodeId=2ef6219408091, content=偏重的研究方向：肿瘤;食管癌;胃肠 经验分享：肠胃相关都可以发，头像找我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231027/c966878f146e4e0dbf8418b9b86fbb57/c2d7036599894bf0b8f0dd9085325554.jpg, createdBy=54379018170, createdName=ms4000000361701675, createdTime=Tue Mar 19 15:26:51 CST 2024, time=2024-03-19, status=1, ipAttribution=广西)]

2022-04-14 燚燚燚

那个提交稿件统计学证明，大佬都在呢整得哇，求助。

62 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2111599, encodeId=3ab5211159967, content=偏重的研究方向：肿瘤;胃肠 经验分享：邀请投稿，第一个审稿人评分DC，给的大修，不知道会不会给大修的机会😔, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab055420094, createdName=少年宁, createdTime=Fri Jan 27 10:22:04 CST 2023, time=2023-01-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=588958, encodeId=da425889587c, content=结果怎么样？审稿快吗？136bxNT2201(暂无昵称) 2019-09-21 00:00:00 发表: 投了, beContent=136bxNT2201(暂无昵称) 2019-09-21 00:00:00 发表: 投了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa555318674, createdName=148a31cbm82暂无昵称, createdTime=Wed Apr 15 00:00:00 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203712, encodeId=341b1203e12de, content=一个case而已，超级多审稿人，用的着吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/11/27/02ec99199da3be64e02e6f44937ab158.jpg, createdBy=1c582101660, createdName=john2525, createdTime=Fri Mar 18 09:38:37 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966262, encodeId=79fa9662623a, content=请问有没有投中的啊 2.22投现在还在under review 毕业想撤稿了😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2ea65502954, createdName=zhangy, createdTime=Mon May 17 14:37:00 CST 2021, time=2021-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211284, encodeId=9f4512112849b, content=那个提交稿件统计学证明，大佬都在呢整得哇，求助。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220410/72abed6ca19c4aca86961c1291a3a3c6/e23fe3265bd64221b9f3d1f39f00a99f.jpg, createdBy=6a3e5632321, createdName=燚燚燚, createdTime=Thu Apr 14 22:34:11 CST 2022, time=2022-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098499, encodeId=172e20984998e, content=reviewed 是在什么阶段, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c992146749, createdName=经胸微创, createdTime=Fri Nov 04 15:25:14 CST 2022, time=2022-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2163083, encodeId=71d2216308318, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：食管癌 经验分享：有没有人知道这个期刊的审稿状态啊，reviewing是什么阶段啊，求大佬告知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af406151852, createdName=ms8000000868362155, createdTime=Mon Oct 16 15:24:30 CST 2023, time=2023-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225203, encodeId=9afb122520311, content=偏重的研究方向：肿瘤 经验分享：投稿1个月了，AI发送了很多审稿人，到现在也没有一个审稿意见，很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ffe2800746, createdName=504528319, createdTime=Wed Jun 08 15:27:15 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566145, encodeId=bb1a56614542, content=没有人投这个杂志吗？一点信息都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/12/28/80eebc88df7aaad2c9eb32ecfb284595.jpg, createdBy=cbef1645356, createdName=ysynl, createdTime=Fri Jan 25 00:00:00 CST 2019, time=2019-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2194080, encodeId=2ef6219408091, content=偏重的研究方向：肿瘤;食管癌;胃肠 经验分享：肠胃相关都可以发，头像找我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231027/c966878f146e4e0dbf8418b9b86fbb57/c2d7036599894bf0b8f0dd9085325554.jpg, createdBy=54379018170, createdName=ms4000000361701675, createdTime=Tue Mar 19 15:26:51 CST 2024, time=2024-03-19, status=1, ipAttribution=广西)]

2022-11-04 经胸微创

reviewed 是在什么阶段

49 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2111599, encodeId=3ab5211159967, content=偏重的研究方向：肿瘤;胃肠 经验分享：邀请投稿，第一个审稿人评分DC，给的大修，不知道会不会给大修的机会😔, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab055420094, createdName=少年宁, createdTime=Fri Jan 27 10:22:04 CST 2023, time=2023-01-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=588958, encodeId=da425889587c, content=结果怎么样？审稿快吗？136bxNT2201(暂无昵称) 2019-09-21 00:00:00 发表: 投了, beContent=136bxNT2201(暂无昵称) 2019-09-21 00:00:00 发表: 投了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa555318674, createdName=148a31cbm82暂无昵称, createdTime=Wed Apr 15 00:00:00 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203712, encodeId=341b1203e12de, content=一个case而已，超级多审稿人，用的着吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/11/27/02ec99199da3be64e02e6f44937ab158.jpg, createdBy=1c582101660, createdName=john2525, createdTime=Fri Mar 18 09:38:37 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966262, encodeId=79fa9662623a, content=请问有没有投中的啊 2.22投现在还在under review 毕业想撤稿了😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2ea65502954, createdName=zhangy, createdTime=Mon May 17 14:37:00 CST 2021, time=2021-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211284, encodeId=9f4512112849b, content=那个提交稿件统计学证明，大佬都在呢整得哇，求助。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220410/72abed6ca19c4aca86961c1291a3a3c6/e23fe3265bd64221b9f3d1f39f00a99f.jpg, createdBy=6a3e5632321, createdName=燚燚燚, createdTime=Thu Apr 14 22:34:11 CST 2022, time=2022-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098499, encodeId=172e20984998e, content=reviewed 是在什么阶段, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c992146749, createdName=经胸微创, createdTime=Fri Nov 04 15:25:14 CST 2022, time=2022-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2163083, encodeId=71d2216308318, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：食管癌 经验分享：有没有人知道这个期刊的审稿状态啊，reviewing是什么阶段啊，求大佬告知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af406151852, createdName=ms8000000868362155, createdTime=Mon Oct 16 15:24:30 CST 2023, time=2023-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225203, encodeId=9afb122520311, content=偏重的研究方向：肿瘤 经验分享：投稿1个月了，AI发送了很多审稿人，到现在也没有一个审稿意见，很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ffe2800746, createdName=504528319, createdTime=Wed Jun 08 15:27:15 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566145, encodeId=bb1a56614542, content=没有人投这个杂志吗？一点信息都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/12/28/80eebc88df7aaad2c9eb32ecfb284595.jpg, createdBy=cbef1645356, createdName=ysynl, createdTime=Fri Jan 25 00:00:00 CST 2019, time=2019-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2194080, encodeId=2ef6219408091, content=偏重的研究方向：肿瘤;食管癌;胃肠 经验分享：肠胃相关都可以发，头像找我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231027/c966878f146e4e0dbf8418b9b86fbb57/c2d7036599894bf0b8f0dd9085325554.jpg, createdBy=54379018170, createdName=ms4000000361701675, createdTime=Tue Mar 19 15:26:51 CST 2024, time=2024-03-19, status=1, ipAttribution=广西)]

2023-10-16 ms8000000868362155

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：食管癌
经验分享：有没有人知道这个期刊的审稿状态啊，reviewing是什么阶段啊，求大佬告知

36 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2111599, encodeId=3ab5211159967, content=偏重的研究方向：肿瘤;胃肠 经验分享：邀请投稿，第一个审稿人评分DC，给的大修，不知道会不会给大修的机会😔, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab055420094, createdName=少年宁, createdTime=Fri Jan 27 10:22:04 CST 2023, time=2023-01-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=588958, encodeId=da425889587c, content=结果怎么样？审稿快吗？136bxNT2201(暂无昵称) 2019-09-21 00:00:00 发表: 投了, beContent=136bxNT2201(暂无昵称) 2019-09-21 00:00:00 发表: 投了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa555318674, createdName=148a31cbm82暂无昵称, createdTime=Wed Apr 15 00:00:00 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203712, encodeId=341b1203e12de, content=一个case而已，超级多审稿人，用的着吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/11/27/02ec99199da3be64e02e6f44937ab158.jpg, createdBy=1c582101660, createdName=john2525, createdTime=Fri Mar 18 09:38:37 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966262, encodeId=79fa9662623a, content=请问有没有投中的啊 2.22投现在还在under review 毕业想撤稿了😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2ea65502954, createdName=zhangy, createdTime=Mon May 17 14:37:00 CST 2021, time=2021-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211284, encodeId=9f4512112849b, content=那个提交稿件统计学证明，大佬都在呢整得哇，求助。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220410/72abed6ca19c4aca86961c1291a3a3c6/e23fe3265bd64221b9f3d1f39f00a99f.jpg, createdBy=6a3e5632321, createdName=燚燚燚, createdTime=Thu Apr 14 22:34:11 CST 2022, time=2022-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098499, encodeId=172e20984998e, content=reviewed 是在什么阶段, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c992146749, createdName=经胸微创, createdTime=Fri Nov 04 15:25:14 CST 2022, time=2022-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2163083, encodeId=71d2216308318, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：食管癌 经验分享：有没有人知道这个期刊的审稿状态啊，reviewing是什么阶段啊，求大佬告知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af406151852, createdName=ms8000000868362155, createdTime=Mon Oct 16 15:24:30 CST 2023, time=2023-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225203, encodeId=9afb122520311, content=偏重的研究方向：肿瘤 经验分享：投稿1个月了，AI发送了很多审稿人，到现在也没有一个审稿意见，很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ffe2800746, createdName=504528319, createdTime=Wed Jun 08 15:27:15 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566145, encodeId=bb1a56614542, content=没有人投这个杂志吗？一点信息都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/12/28/80eebc88df7aaad2c9eb32ecfb284595.jpg, createdBy=cbef1645356, createdName=ysynl, createdTime=Fri Jan 25 00:00:00 CST 2019, time=2019-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2194080, encodeId=2ef6219408091, content=偏重的研究方向：肿瘤;食管癌;胃肠 经验分享：肠胃相关都可以发，头像找我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231027/c966878f146e4e0dbf8418b9b86fbb57/c2d7036599894bf0b8f0dd9085325554.jpg, createdBy=54379018170, createdName=ms4000000361701675, createdTime=Tue Mar 19 15:26:51 CST 2024, time=2024-03-19, status=1, ipAttribution=广西)]

2022-06-08 504528319

偏重的研究方向：肿瘤
经验分享：投稿1个月了，AI发送了很多审稿人，到现在也没有一个审稿意见，很慢

49 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2111599, encodeId=3ab5211159967, content=偏重的研究方向：肿瘤;胃肠 经验分享：邀请投稿，第一个审稿人评分DC，给的大修，不知道会不会给大修的机会😔, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab055420094, createdName=少年宁, createdTime=Fri Jan 27 10:22:04 CST 2023, time=2023-01-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=588958, encodeId=da425889587c, content=结果怎么样？审稿快吗？136bxNT2201(暂无昵称) 2019-09-21 00:00:00 发表: 投了, beContent=136bxNT2201(暂无昵称) 2019-09-21 00:00:00 发表: 投了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa555318674, createdName=148a31cbm82暂无昵称, createdTime=Wed Apr 15 00:00:00 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203712, encodeId=341b1203e12de, content=一个case而已，超级多审稿人，用的着吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/11/27/02ec99199da3be64e02e6f44937ab158.jpg, createdBy=1c582101660, createdName=john2525, createdTime=Fri Mar 18 09:38:37 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966262, encodeId=79fa9662623a, content=请问有没有投中的啊 2.22投现在还在under review 毕业想撤稿了😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2ea65502954, createdName=zhangy, createdTime=Mon May 17 14:37:00 CST 2021, time=2021-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211284, encodeId=9f4512112849b, content=那个提交稿件统计学证明，大佬都在呢整得哇，求助。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220410/72abed6ca19c4aca86961c1291a3a3c6/e23fe3265bd64221b9f3d1f39f00a99f.jpg, createdBy=6a3e5632321, createdName=燚燚燚, createdTime=Thu Apr 14 22:34:11 CST 2022, time=2022-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098499, encodeId=172e20984998e, content=reviewed 是在什么阶段, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c992146749, createdName=经胸微创, createdTime=Fri Nov 04 15:25:14 CST 2022, time=2022-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2163083, encodeId=71d2216308318, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：食管癌 经验分享：有没有人知道这个期刊的审稿状态啊，reviewing是什么阶段啊，求大佬告知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af406151852, createdName=ms8000000868362155, createdTime=Mon Oct 16 15:24:30 CST 2023, time=2023-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225203, encodeId=9afb122520311, content=偏重的研究方向：肿瘤 经验分享：投稿1个月了，AI发送了很多审稿人，到现在也没有一个审稿意见，很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ffe2800746, createdName=504528319, createdTime=Wed Jun 08 15:27:15 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566145, encodeId=bb1a56614542, content=没有人投这个杂志吗？一点信息都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/12/28/80eebc88df7aaad2c9eb32ecfb284595.jpg, createdBy=cbef1645356, createdName=ysynl, createdTime=Fri Jan 25 00:00:00 CST 2019, time=2019-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2194080, encodeId=2ef6219408091, content=偏重的研究方向：肿瘤;食管癌;胃肠 经验分享：肠胃相关都可以发，头像找我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231027/c966878f146e4e0dbf8418b9b86fbb57/c2d7036599894bf0b8f0dd9085325554.jpg, createdBy=54379018170, createdName=ms4000000361701675, createdTime=Tue Mar 19 15:26:51 CST 2024, time=2024-03-19, status=1, ipAttribution=广西)]

2019-01-25 ysynl

没有人投这个杂志吗？一点信息都没有

155 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2111599, encodeId=3ab5211159967, content=偏重的研究方向：肿瘤;胃肠 经验分享：邀请投稿，第一个审稿人评分DC，给的大修，不知道会不会给大修的机会😔, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab055420094, createdName=少年宁, createdTime=Fri Jan 27 10:22:04 CST 2023, time=2023-01-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=588958, encodeId=da425889587c, content=结果怎么样？审稿快吗？136bxNT2201(暂无昵称) 2019-09-21 00:00:00 发表: 投了, beContent=136bxNT2201(暂无昵称) 2019-09-21 00:00:00 发表: 投了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa555318674, createdName=148a31cbm82暂无昵称, createdTime=Wed Apr 15 00:00:00 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203712, encodeId=341b1203e12de, content=一个case而已，超级多审稿人，用的着吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/11/27/02ec99199da3be64e02e6f44937ab158.jpg, createdBy=1c582101660, createdName=john2525, createdTime=Fri Mar 18 09:38:37 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966262, encodeId=79fa9662623a, content=请问有没有投中的啊 2.22投现在还在under review 毕业想撤稿了😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2ea65502954, createdName=zhangy, createdTime=Mon May 17 14:37:00 CST 2021, time=2021-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211284, encodeId=9f4512112849b, content=那个提交稿件统计学证明，大佬都在呢整得哇，求助。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220410/72abed6ca19c4aca86961c1291a3a3c6/e23fe3265bd64221b9f3d1f39f00a99f.jpg, createdBy=6a3e5632321, createdName=燚燚燚, createdTime=Thu Apr 14 22:34:11 CST 2022, time=2022-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098499, encodeId=172e20984998e, content=reviewed 是在什么阶段, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c992146749, createdName=经胸微创, createdTime=Fri Nov 04 15:25:14 CST 2022, time=2022-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2163083, encodeId=71d2216308318, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：食管癌 经验分享：有没有人知道这个期刊的审稿状态啊，reviewing是什么阶段啊，求大佬告知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af406151852, createdName=ms8000000868362155, createdTime=Mon Oct 16 15:24:30 CST 2023, time=2023-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225203, encodeId=9afb122520311, content=偏重的研究方向：肿瘤 经验分享：投稿1个月了，AI发送了很多审稿人，到现在也没有一个审稿意见，很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ffe2800746, createdName=504528319, createdTime=Wed Jun 08 15:27:15 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566145, encodeId=bb1a56614542, content=没有人投这个杂志吗？一点信息都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/12/28/80eebc88df7aaad2c9eb32ecfb284595.jpg, createdBy=cbef1645356, createdName=ysynl, createdTime=Fri Jan 25 00:00:00 CST 2019, time=2019-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2194080, encodeId=2ef6219408091, content=偏重的研究方向：肿瘤;食管癌;胃肠 经验分享：肠胃相关都可以发，头像找我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231027/c966878f146e4e0dbf8418b9b86fbb57/c2d7036599894bf0b8f0dd9085325554.jpg, createdBy=54379018170, createdName=ms4000000361701675, createdTime=Tue Mar 19 15:26:51 CST 2024, time=2024-03-19, status=1, ipAttribution=广西)]

2024-03-19 ms4000000361701675 来自广西

偏重的研究方向：肿瘤;食管癌;胃肠
经验分享：肠胃相关都可以发，头像找我

13 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务